| mRNA |
Bortezomib |
GDSC1000 |
pan-cancer |
AAC |
-0.0052 |
0.9 |
| mRNA |
LY-2157299 |
CTRPv2 |
pan-cancer |
AAC |
-0.008 |
0.9 |
| mRNA |
MS-275 |
gCSI |
pan-cancer |
AAC |
-0.0046 |
0.9 |
| mRNA |
AG-014699 |
GDSC1000 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0031 |
0.9 |
| mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
-0.0071 |
0.9 |
| mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.0047 |
0.9 |
| mRNA |
GW-2580 |
GDSC1000 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
| mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |
| mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
0.0042 |
0.9 |